STOCK TITAN
  1. Home
  2. Sec-filings
  3. CMND
  4. [EFFECT] Clearmind Medicine Inc. SEC Filing

[EFFECT] Clearmind Medicine Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 30, 2026
Accession Number: 0001213900-26-034076
Submission Type: POS AM
CIK: 0001892500
Company Name: Clearmind Medicine Inc.
File Number: 333-291817

Source: View Original Filing on SEC EDGAR

Clearmind Medici

NASDAQ:CMND

View CMND Stock Overview →

CMND Rankings

#6957 Ranked by Market Cap
N/A Ranked by Dividends

CMND Latest News

Mar 30, 2026
Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
Mar 27, 2026
Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
Mar 19, 2026
Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder
Mar 17, 2026
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
Mar 13, 2026
Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy

CMND Latest SEC Filings

Mar 31, 2026
[EFFECT] Clearmind Medicine Inc. SEC Filing
Mar 30, 2026
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer)
Mar 27, 2026
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer)
Mar 25, 2026
[POS AM] Clearmind Medicine Inc. SEC Filing
Mar 25, 2026
[POS AM] Clearmind Medicine Inc. SEC Filing

CMND Stock Data

2.09M
2.02M
Biotechnology
Healthcare
Link
Canada
Vancouver